Clinical Trials
All Clinical Trials - Page 35 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT02490150Phase 4Completed
Corifollitropin Alfa on D5 Versus D7 After Contraceptive Pill
Gonadorelin
- NCT02603679Phase 2Active Not Recruiting
Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases
Gonadorelin
- NCT02351232Phase 2/Phase 3Completed
The Lira Pump Trial
Liraglutide
- NCT02887625N/AUnknown
Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM
Exenatide
- NCT02245620Phase 2Completed
A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in Elderly
Elamipretide
- NCT02338960Phase 3Completed
2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
PT-141
- NCT02281266Phase 4Unknown
Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative Resection
Thymosin-Alpha-1
- NCT01858051N/AWithdrawn
Vitamin D Status in Lower Extremity Joint Replacement Surgery Patients
Ll-37
- NCT02354781Phase 1/Phase 2Completed
Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy
Follistatin
- NCT02335736Phase 2Unknown
Antagonist Protocol in IVF
Gonadorelin
- NCT02408705Phase 2Completed
Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
Liraglutide
- NCT02650206Phase 1Completed
Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood
Liraglutide
- NCT02608853N/ACompleted
Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to be Representative of Liraglutide Initiators and LEADER™ Trial Participants
Liraglutide
- NCT02344641N/AUnknown
Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients
Exenatide
- NCT02380521Phase 4Completed
Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes
Exenatide
- NCT01969149Phase 2/Phase 3Completed
Exenatide for Stress Hyperglycemia
Exenatide
- NCT02325960Phase 4Completed
A Comparison of Exenatide and Insulin Glargine
Exenatide
- NCT02305381Phase 3Completed
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes
Semaglutide
- NCT02333071Phase 3Completed
1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
PT-141
- NCT02271282Phase 1Completed
Estradiol-Receptor Blockade in Older Men and Women
Sermorelin
- NCT02313051Phase 2Unknown
Everolimus trIal for Advanced prememopausaL Breast Cancer Patients
Gonadorelin
- NCT02288130Phase 4Unknown
Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy
Gonadorelin
- NCT03619330Phase 4Completed
Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.
Liraglutide
- NCT02284230Phase 2Withdrawn
The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure
Liraglutide
- NCT02313220Phase 2Completed
Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight
Exenatide
- NCT02288273Phase 4Completed
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.
Exenatide
- NCT02298192Phase 3Completed
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
Liraglutide
- NCT02278120Phase 3Completed
Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
Gonadorelin
- NCT02314299Phase 1/Phase 2Completed
A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration
Elamipretide
- NCT02324842N/ACompleted
Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients
Liraglutide
- NCT01966978Phase 4Completed
The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
Liraglutide
- NCT02302976Phase 1Completed
GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration
Exenatide
- NCT02320045Phase 1Completed
Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects
Exenatide
- NCT02974244N/ACompleted
Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins
Exenatide
- NCT02254291Phase 3Completed
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes
Semaglutide
- NCT02487823Phase 1Terminated
Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer
Gonadorelin
- NCT02268175Phase 2Completed
Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate
Gonadorelin
- NCT02244164N/ATerminated
Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
Liraglutide
- NCT02501850Phase 4Unknown
The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
Liraglutide
- NCT02299388Phase 4Completed
To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study
Liraglutide
- NCT02217566Phase 2Completed
Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy
Gonadorelin
- NCT02249910Phase 1Completed
Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects
Semaglutide
- NCT02122198N/ACompleted
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
Gonadorelin
- NCT02229383Phase 3Completed
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
Exenatide
- NCT02235961Phase 1Completed
Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects
Liraglutide
- NCT02229396Phase 3Completed
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
Exenatide
- NCT03353948Phase 4Completed
The Effect of a Liraglutide on IVF in Obese PCOS
Liraglutide
- NCT02231684Phase 1Completed
Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of Semaglutide
Semaglutide
- NCT02234089N/ACompleted
Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists.
Gonadorelin
- NCT02212197Phase 2Completed
Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer
Gonadorelin